Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

17.98
-0.0500-0.28%
Pre-market: 18.110.1300+0.72%08:18 EDT
Volume:1.78M
Turnover:32.03M
Market Cap:57.22B
PE:-56.47
High:18.06
Open:17.99
Low:17.96
Close:18.03
52wk High:18.90
52wk Low:12.99
Shares:3.18B
Float Shares:3.09B
Volume Ratio:0.95
T/O Rate:0.06%
Dividend:0.62
Dividend Rate:3.47%
EPS(TTM):-0.3184
EPS(LYR):-0.3042
ROE:-2.26%
ROA:2.69%
PB:1.21
PE(LYR):-59.10

Loading ...

Takeda Pharmaceutical Q1 Adj. EPS $0.48 Beats $0.39 Estimate, Sales $7.655B Beat $7.060B Estimate

Benzinga Earnings
·
Jul 30

Press Release: Takeda Announces Fy2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track

Dow Jones
·
Jul 30

Takeda’s Pediatric GERD Trial Update: What Dexlansoprazole Data Could Mean for TAK Investors

TIPRANKS
·
Jul 30

Takeda Pharmaceutical Co Ltd Expected to Post Earnings of Jpy140.99 a Share - Earnings Preview

Reuters
·
Jul 28

Takeda Expected to Post Lower First-Quarter Net Profit

Dow Jones
·
Jul 28

Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK

TIPRANKS
·
Jul 25

Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

MT Newswires Live
·
Jul 24

Earning Preview: Takeda Pharmaceutical Co Ltd Q1 revenue is expected to decrease by 1.08%, and institutional views are bullish

Earnings Agent
·
Jul 24

Immigration: Foreign Lawbreakers May Face Indonesian Prison

Tempo
·
Jul 23

Takeda Pharmaceutical Reports Positive Phase 3 Data for Zasocitinib in Moderate-to-Severe Plaque Psoriasis

MT Newswires Live
·
Jul 17

Takeda’s TAK-226 Anemia Trial Offers New Optionality in Hematology

TIPRANKS
·
Jul 17

Takeda Extends TAK-360 Sleep Trial, Signaling Long-Term Ambitions in Narcolepsy

TIPRANKS
·
Jul 16

Takeda, Indonesian Government Launch Program to Build National Plasma Ecosystem

MT Newswires Live
·
Jul 13

Takeda, the Indoensian Government announce collaboration

TIPRANKS
·
Jul 13

Insilico Medicine Announces Strategic Collaboration with Takeda for AI-Driven Drug Discovery

Stock News
·
Jul 02

Takeda, Insilico Strike AI Drug-discovery Deal Worth up to $600.0 Million

Dow Jones
·
Jul 02

Alkermes Faces Risk on Orexin-Related Value From Upcoming Updates, BofA Says

MT Newswires Live
·
Jun 29

Takeda's First Female CEO Outlines Strategy for Growth Rebound and Major Product Launches

Stock News
·
Jun 25

Takeda Pharmaceutical Appoints Julie Kim as Chief Executive

MT Newswires Live
·
Jun 24

Asian Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading

MT Newswires Live
·
Jun 23